{"id":339862,"date":"2025-08-19T19:11:39","date_gmt":"2025-08-19T19:11:39","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-humana\/"},"modified":"2025-08-19T19:11:39","modified_gmt":"2025-08-19T19:11:39","slug":"how-to-buy-humana","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/","title":{"rendered":"How to buy Humana Inc. (HUM) shares &#8211; Investment in Humana Inc. (HUM) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334027,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-339862","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Humana Inc. (HUM) Shares - Investment in Humana Inc. (HUM) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Humana Inc. (HUM) Shares - Investment in Humana Inc. (HUM) Stock"},"description":"Learn how to invest in Humana Inc. (HUM) stock with current price analysis, risk assessment, and step-by-step buying process for 2025 market conditions.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to invest in Humana Inc. (HUM) stock with current price analysis, risk assessment, and step-by-step buying process for 2025 market conditions."},"intro":"Thinking about adding healthcare stability to your portfolio? Humana Inc. represents one of America's largest Medicare Advantage providers with a fascinating growth story. This isn't just another insurance stock\u2014it's a company transforming senior healthcare delivery while navigating regulatory waves. Let's explore why HUM deserves your attention and how to make it part of your investment journey.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about adding healthcare stability to your portfolio? Humana Inc. represents one of America's largest Medicare Advantage providers with a fascinating growth story. This isn't just another insurance stock\u2014it's a company transforming senior healthcare delivery while navigating regulatory waves. Let's explore why HUM deserves your attention and how to make it part of your investment journey."},"body_html":"<h2>\ud83d\udcc8 Humana Stock Analysis: Current Price and Critical Dates<\/h2> <p>As of August 19, 2025, Humana Inc. (HUM) trades at <strong>$287.75<\/strong> on the NYSE. This price reflects a remarkable recovery from recent lows, but the real action happens around earnings season.<\/p> <p><strong>Mark your calendar: October 29, 2025<\/strong> is your next major volatility event. That's when Humana releases Q3 earnings, and history shows these reports can move the needle significantly.<\/p> <h3>Earnings Impact Analysis: How HUM Reacts to News<\/h3> <p>Looking at recent quarterly performances reveals a pattern every trader should understand:<\/p> <table> <thead> <tr><th>Quarter<\/th><th>Date<\/th><th>EPS Estimate<\/th><th>Actual EPS<\/th><th>Price Impact<\/th><\/tr> <\/thead> <tbody> <tr><td>Q2 2025<\/td><td>Jul 30<\/td><td>$6.05-$6.32<\/td><td>$6.27<\/td><td>Mixed reaction (missed some estimates)<\/td><\/tr> <tr><td>Q1 2025<\/td><td>Apr 30<\/td><td>$10.07<\/td><td>$11.58<\/td><td>+15% beat \u2192 Positive momentum<\/td><\/tr> <tr><td>Q4 2024<\/td><td>Feb 11<\/td><td>-$2.12<\/td><td>-$2.16<\/td><td>Slight beat during seasonal weakness<\/td><\/tr> <tr><td>Q3 2024<\/td><td>Oct 30<\/td><td>$3.40<\/td><td>$4.16<\/td><td>+22% beat \u2192 Significant rally<\/td><\/tr> <\/tbody> <\/table> <p>The pattern is clear: Humana consistently beats expectations, but the market reaction depends on which estimates they're measured against. The Q2 2025 results showed this perfectly\u2014some analysts called it a beat, others a miss, creating confusion and muted price movement.<\/p> <h3>6-Month Price Journey: From Panic to Recovery<\/h3> <p>Humana's stock has been on an emotional rollercoaster since February 2025:<\/p> <ul> <li><strong>February-March 2025<\/strong>: Trading around $300-320 range, relatively stable<\/li> <li><strong>April 2025<\/strong>: Surged to $340+ following stellar Q1 earnings beat<\/li> <li><strong>May 2025<\/strong>: Collapsed to $212.45 (period low) on regulatory fears<\/li> <li><strong>June-July 2025<\/strong>: Gradual recovery to $250-270 range<\/li> <li><strong>August 2025<\/strong>: Explosive rally to current $287.75 (+35% from May lows)<\/li> <\/ul> <p>This volatility isn't random\u2014it directly correlates with Medicare Advantage regulatory news and earnings surprises. The May crash coincided with CMS star rating downgrades, while the August surge followed solid Q2 revenue growth of 9.6% year-over-year.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on current analyst consensus and regulatory environment, here's what to expect:<\/p> <p><strong>2025 Year-End<\/strong>: $280-310 range (Hold recommendation)<\/p> <ul> <li>Conservative targets around $279.86 suggest minimal upside<\/li> <li>Optimistic models project $403+ but regulatory headwinds may limit gains<\/li> <\/ul> <p><strong>2026 Projection<\/strong>: $245-270 (Cautious growth)<\/p> <ul> <li>Medicare Advantage margin pressures likely to continue<\/li> <li>CenterWell expansion provides partial offset<\/li> <\/ul> <p><strong>2028 Outlook<\/strong>: $340-380 (Recovery phase)<\/p> <ul> <li>Regulatory environment should stabilize<\/li> <li>Value-based care models gain traction<\/li> <\/ul> <p><strong>2030 Vision<\/strong>: $400-450 (Transformation payoff)<\/p> <ul> <li>Integrated care delivery shows full benefits<\/li> <li>Demographic tailwinds from aging population<\/li> <\/ul> <p><strong>Verdict<\/strong>: HOLD for now, accumulate on dips below $260. The regulatory overhang creates buying opportunities for patient investors.<\/p> <h2>\u26a0\ufe0f Risk Assessment: What Keeps HUM Executives Awake at Night<\/h2> <h3>Regulatory Risks (High Severity)<\/h3> <ul> <li><strong>CMS Star Ratings litigation<\/strong>: Ongoing lawsuit against 2025 downgrade that crushed quality bonuses<\/li> <li><strong>Audit expansion<\/strong>: CMS increasing medical coders from 40 to 2,000 by September 2025 targeting risk adjustment validation<\/li> <li><strong>Agent compensation caps<\/strong>: $411 limit per enrollment reducing sales motivation<\/li> <\/ul> <h3>Operational Challenges (Medium Severity)<\/h3> <ul> <li><strong>Medicare Advantage margin pressure<\/strong>: Struggling to maintain target 3% margins<\/li> <li><strong>Membership decline<\/strong>: Individual MA enrollment dropping amid regulatory changes<\/li> <li><strong>Integration complexity<\/strong>: Merging insurance with healthcare delivery operations<\/li> <\/ul> <h3>Market Risks (Medium Severity)<\/h3> <ul> <li><strong>High institutional ownership<\/strong>: 92% institutional ownership means large blocks can move prices fast<\/li> <li><strong>Sector rotation<\/strong>: Healthcare out-of-favor during certain market cycles<\/li> <li><strong>Interest rate sensitivity<\/strong>: Debt financing costs affecting expansion plans<\/li> <\/ul> <h2>\ud83d\ude80 Positive Catalysts: Why HUM Could Surprise Everyone<\/h2> <h3>Near-Term Boosters (2025)<\/h3> <ul> <li><strong>CenterWell growth<\/strong>: 11.9% revenue increase in home health services<\/li> <li><strong>Market share gains<\/strong>: 12% member growth year-to-date, targeting 15% by year-end<\/li> <li><strong>Operational efficiency<\/strong>: Improved clinical productivity and onehome profitability<\/li> <\/ul> <h3>Medium-Term Drivers (2026-2027)<\/h3> <ul> <li><strong>Demographic tsunami<\/strong>: 10,000 Americans turning 65 daily until 2030<\/li> <li><strong>Value-based care adoption<\/strong>: Proven better outcomes than fee-for-service models<\/li> <li><strong>Technology integration<\/strong>: AI and data analytics improving care coordination<\/li> <\/ul> <h3>Long-Term Advantages (2028+)<\/h3> <ul> <li><strong>Brand recognition<\/strong>: Top-tier Medicare Advantage provider reputation<\/li> <li><strong>Vertical integration<\/strong>: Unique insurance+care delivery model moat<\/li> <li><strong>Scale benefits<\/strong>: Operating leverage across 50 states<\/li> <\/ul> <h2>\ud83d\udcf0 Recent News Analysis: What Matters for Traders<\/h2> <p>Humana's Q2 2025 results delivered mixed signals that created trading opportunities:<\/p> <p><strong>The Good News<\/strong>: Revenue hit $32.39 billion (+9.6% YoY), beating expectations primarily through CenterWell's strong performance. The home health division generated $5.5 billion (+11.9%) with same-store admissions growing about 1%. CEO Jim Rechtin emphasized their \"multi-year transformation initiatives\" targeting scalable growth.<\/p> <p><strong>The Concerning News<\/strong>: EPS of $6.27 missed some consensus estimates (particularly the $6.32 expectation), and adjusted earnings declined 9.9% year-over-year due to higher benefit costs. The ongoing legal battle against CMS regarding star rating downgrades adds uncertainty.<\/p> <p><strong>Trader Takeaway<\/strong>: Revenue growth suggests underlying business strength, but margin pressure and regulatory fights create headwinds. This divergence creates range-bound trading opportunities.<\/p> <h2>\ud83c\udfaf Beginner Trader Action Plan Today<\/h2> <h3>Serious Recommendations:<\/h3> <ol> <li><strong>Wait for earnings dip<\/strong>: October 29th earnings often create better entry points<\/li> <li><strong>Dollar-cost average<\/strong>: Start with small positions and add on regulatory fear spikes<\/li> <li><strong>Set alert at $260<\/strong>: Strong support level based on recent trading patterns<\/li> <\/ol> <h3>Humorous Veteran Wisdom:<\/h3> <p>\"Trading HUM is like dating someone in healthcare administration\u2014there's paperwork, regulatory drama, but eventually they'll take good care of you in your golden years. Just don't expect constant excitement!\"<\/p> <h2>\u2705 How to Buy Humana Inc. (HUM) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a trading platform<\/td><td>Ensure it offers NYSE access and reasonable commissions<\/td><\/tr> <tr><td>2<\/td><td>Complete account funding<\/td><td>Start with amount you're comfortable risking on healthcare volatility<\/td><\/tr> <tr><td>3<\/td><td>Research current valuation<\/td><td>Check P\/E (~22x), analyst ratings (mostly Hold), and recent news<\/td><\/tr> <tr><td>4<\/td><td>Set limit order around $275-285<\/td><td>Avoid market orders during earnings season volatility<\/td><\/tr> <tr><td>5<\/td><td>Monitor regulatory developments<\/td><td>CMS announcements can move prices 10%+ in single sessions<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Complements Traditional Investing<\/h2> <p>While building long-term HUM positions, Pocket Option offers unique advantages for testing healthcare sector theories:<\/p> <ul> <li><strong>Minimum deposit just $5<\/strong> - Experiment with healthcare sector predictions without major capital commitment<\/li> <li><strong>Rapid verification<\/strong> - Single document KYC gets you trading in minutes, not days<\/li> <li><strong>Diverse withdrawal options<\/strong> - Multiple ways to access profits from successful trades<\/li> <\/ul> <p>The platform's quick trading features let you capitalize on short-term Medicare policy announcements while maintaining core HUM positions in your traditional brokerage.<\/p> <h2>\ud83c\udfe5 Humana in 2025: Healthcare's Integrated Future<\/h2> <p>Humana isn't just an insurance company anymore\u2014it's becoming a vertically integrated healthcare delivery system. With CenterWell expanding into 11 states and entering 4 new markets, they're building something unique: insurance coverage combined with actual care provision.<\/p> <p>The company dominates Medicare Advantage with approximately 28% market share among major providers. Their secret sauce? The CenterWell primary care model where doctors spend 50% more time with patients than typical providers, creating better outcomes and lower costs.<\/p> <p><strong>Interesting 2025 Fact<\/strong>: Humana's research partnership with Harvard proved their value-based care model delivers superior access compared to traditional primary care. They're not just selling insurance\u2014they're reinventing senior healthcare delivery.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Humana Stock Analysis: Current Price and Critical Dates<\/h2>\n<p>As of August 19, 2025, Humana Inc. (HUM) trades at <strong>$287.75<\/strong> on the NYSE. This price reflects a remarkable recovery from recent lows, but the real action happens around earnings season.<\/p>\n<p><strong>Mark your calendar: October 29, 2025<\/strong> is your next major volatility event. That&#8217;s when Humana releases Q3 earnings, and history shows these reports can move the needle significantly.<\/p>\n<h3>Earnings Impact Analysis: How HUM Reacts to News<\/h3>\n<p>Looking at recent quarterly performances reveals a pattern every trader should understand:<\/p>\n<table>\n<thead>\n<tr>\n<th>Quarter<\/th>\n<th>Date<\/th>\n<th>EPS Estimate<\/th>\n<th>Actual EPS<\/th>\n<th>Price Impact<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Q2 2025<\/td>\n<td>Jul 30<\/td>\n<td>$6.05-$6.32<\/td>\n<td>$6.27<\/td>\n<td>Mixed reaction (missed some estimates)<\/td>\n<\/tr>\n<tr>\n<td>Q1 2025<\/td>\n<td>Apr 30<\/td>\n<td>$10.07<\/td>\n<td>$11.58<\/td>\n<td>+15% beat \u2192 Positive momentum<\/td>\n<\/tr>\n<tr>\n<td>Q4 2024<\/td>\n<td>Feb 11<\/td>\n<td>-$2.12<\/td>\n<td>-$2.16<\/td>\n<td>Slight beat during seasonal weakness<\/td>\n<\/tr>\n<tr>\n<td>Q3 2024<\/td>\n<td>Oct 30<\/td>\n<td>$3.40<\/td>\n<td>$4.16<\/td>\n<td>+22% beat \u2192 Significant rally<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The pattern is clear: Humana consistently beats expectations, but the market reaction depends on which estimates they&#8217;re measured against. The Q2 2025 results showed this perfectly\u2014some analysts called it a beat, others a miss, creating confusion and muted price movement.<\/p>\n<h3>6-Month Price Journey: From Panic to Recovery<\/h3>\n<p>Humana&#8217;s stock has been on an emotional rollercoaster since February 2025:<\/p>\n<ul>\n<li><strong>February-March 2025<\/strong>: Trading around $300-320 range, relatively stable<\/li>\n<li><strong>April 2025<\/strong>: Surged to $340+ following stellar Q1 earnings beat<\/li>\n<li><strong>May 2025<\/strong>: Collapsed to $212.45 (period low) on regulatory fears<\/li>\n<li><strong>June-July 2025<\/strong>: Gradual recovery to $250-270 range<\/li>\n<li><strong>August 2025<\/strong>: Explosive rally to current $287.75 (+35% from May lows)<\/li>\n<\/ul>\n<p>This volatility isn&#8217;t random\u2014it directly correlates with Medicare Advantage regulatory news and earnings surprises. The May crash coincided with CMS star rating downgrades, while the August surge followed solid Q2 revenue growth of 9.6% year-over-year.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on current analyst consensus and regulatory environment, here&#8217;s what to expect:<\/p>\n<p><strong>2025 Year-End<\/strong>: $280-310 range (Hold recommendation)<\/p>\n<ul>\n<li>Conservative targets around $279.86 suggest minimal upside<\/li>\n<li>Optimistic models project $403+ but regulatory headwinds may limit gains<\/li>\n<\/ul>\n<p><strong>2026 Projection<\/strong>: $245-270 (Cautious growth)<\/p>\n<ul>\n<li>Medicare Advantage margin pressures likely to continue<\/li>\n<li>CenterWell expansion provides partial offset<\/li>\n<\/ul>\n<p><strong>2028 Outlook<\/strong>: $340-380 (Recovery phase)<\/p>\n<ul>\n<li>Regulatory environment should stabilize<\/li>\n<li>Value-based care models gain traction<\/li>\n<\/ul>\n<p><strong>2030 Vision<\/strong>: $400-450 (Transformation payoff)<\/p>\n<ul>\n<li>Integrated care delivery shows full benefits<\/li>\n<li>Demographic tailwinds from aging population<\/li>\n<\/ul>\n<p><strong>Verdict<\/strong>: HOLD for now, accumulate on dips below $260. The regulatory overhang creates buying opportunities for patient investors.<\/p>\n<h2>\u26a0\ufe0f Risk Assessment: What Keeps HUM Executives Awake at Night<\/h2>\n<h3>Regulatory Risks (High Severity)<\/h3>\n<ul>\n<li><strong>CMS Star Ratings litigation<\/strong>: Ongoing lawsuit against 2025 downgrade that crushed quality bonuses<\/li>\n<li><strong>Audit expansion<\/strong>: CMS increasing medical coders from 40 to 2,000 by September 2025 targeting risk adjustment validation<\/li>\n<li><strong>Agent compensation caps<\/strong>: $411 limit per enrollment reducing sales motivation<\/li>\n<\/ul>\n<h3>Operational Challenges (Medium Severity)<\/h3>\n<ul>\n<li><strong>Medicare Advantage margin pressure<\/strong>: Struggling to maintain target 3% margins<\/li>\n<li><strong>Membership decline<\/strong>: Individual MA enrollment dropping amid regulatory changes<\/li>\n<li><strong>Integration complexity<\/strong>: Merging insurance with healthcare delivery operations<\/li>\n<\/ul>\n<h3>Market Risks (Medium Severity)<\/h3>\n<ul>\n<li><strong>High institutional ownership<\/strong>: 92% institutional ownership means large blocks can move prices fast<\/li>\n<li><strong>Sector rotation<\/strong>: Healthcare out-of-favor during certain market cycles<\/li>\n<li><strong>Interest rate sensitivity<\/strong>: Debt financing costs affecting expansion plans<\/li>\n<\/ul>\n<h2>\ud83d\ude80 Positive Catalysts: Why HUM Could Surprise Everyone<\/h2>\n<h3>Near-Term Boosters (2025)<\/h3>\n<ul>\n<li><strong>CenterWell growth<\/strong>: 11.9% revenue increase in home health services<\/li>\n<li><strong>Market share gains<\/strong>: 12% member growth year-to-date, targeting 15% by year-end<\/li>\n<li><strong>Operational efficiency<\/strong>: Improved clinical productivity and onehome profitability<\/li>\n<\/ul>\n<h3>Medium-Term Drivers (2026-2027)<\/h3>\n<ul>\n<li><strong>Demographic tsunami<\/strong>: 10,000 Americans turning 65 daily until 2030<\/li>\n<li><strong>Value-based care adoption<\/strong>: Proven better outcomes than fee-for-service models<\/li>\n<li><strong>Technology integration<\/strong>: AI and data analytics improving care coordination<\/li>\n<\/ul>\n<h3>Long-Term Advantages (2028+)<\/h3>\n<ul>\n<li><strong>Brand recognition<\/strong>: Top-tier Medicare Advantage provider reputation<\/li>\n<li><strong>Vertical integration<\/strong>: Unique insurance+care delivery model moat<\/li>\n<li><strong>Scale benefits<\/strong>: Operating leverage across 50 states<\/li>\n<\/ul>\n<h2>\ud83d\udcf0 Recent News Analysis: What Matters for Traders<\/h2>\n<p>Humana&#8217;s Q2 2025 results delivered mixed signals that created trading opportunities:<\/p>\n<p><strong>The Good News<\/strong>: Revenue hit $32.39 billion (+9.6% YoY), beating expectations primarily through CenterWell&#8217;s strong performance. The home health division generated $5.5 billion (+11.9%) with same-store admissions growing about 1%. CEO Jim Rechtin emphasized their &#8220;multi-year transformation initiatives&#8221; targeting scalable growth.<\/p>\n<p><strong>The Concerning News<\/strong>: EPS of $6.27 missed some consensus estimates (particularly the $6.32 expectation), and adjusted earnings declined 9.9% year-over-year due to higher benefit costs. The ongoing legal battle against CMS regarding star rating downgrades adds uncertainty.<\/p>\n<p><strong>Trader Takeaway<\/strong>: Revenue growth suggests underlying business strength, but margin pressure and regulatory fights create headwinds. This divergence creates range-bound trading opportunities.<\/p>\n<h2>\ud83c\udfaf Beginner Trader Action Plan Today<\/h2>\n<h3>Serious Recommendations:<\/h3>\n<ol>\n<li><strong>Wait for earnings dip<\/strong>: October 29th earnings often create better entry points<\/li>\n<li><strong>Dollar-cost average<\/strong>: Start with small positions and add on regulatory fear spikes<\/li>\n<li><strong>Set alert at $260<\/strong>: Strong support level based on recent trading patterns<\/li>\n<\/ol>\n<h3>Humorous Veteran Wisdom:<\/h3>\n<p>&#8220;Trading HUM is like dating someone in healthcare administration\u2014there&#8217;s paperwork, regulatory drama, but eventually they&#8217;ll take good care of you in your golden years. Just don&#8217;t expect constant excitement!&#8221;<\/p>\n<h2>\u2705 How to Buy Humana Inc. (HUM) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a trading platform<\/td>\n<td>Ensure it offers NYSE access and reasonable commissions<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete account funding<\/td>\n<td>Start with amount you&#8217;re comfortable risking on healthcare volatility<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Research current valuation<\/td>\n<td>Check P\/E (~22x), analyst ratings (mostly Hold), and recent news<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Set limit order around $275-285<\/td>\n<td>Avoid market orders during earnings season volatility<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Monitor regulatory developments<\/td>\n<td>CMS announcements can move prices 10%+ in single sessions<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Complements Traditional Investing<\/h2>\n<p>While building long-term HUM positions, Pocket Option offers unique advantages for testing healthcare sector theories:<\/p>\n<ul>\n<li><strong>Minimum deposit just $5<\/strong> &#8211; Experiment with healthcare sector predictions without major capital commitment<\/li>\n<li><strong>Rapid verification<\/strong> &#8211; Single document KYC gets you trading in minutes, not days<\/li>\n<li><strong>Diverse withdrawal options<\/strong> &#8211; Multiple ways to access profits from successful trades<\/li>\n<\/ul>\n<p>The platform&#8217;s quick trading features let you capitalize on short-term Medicare policy announcements while maintaining core HUM positions in your traditional brokerage.<\/p>\n<h2>\ud83c\udfe5 Humana in 2025: Healthcare&#8217;s Integrated Future<\/h2>\n<p>Humana isn&#8217;t just an insurance company anymore\u2014it&#8217;s becoming a vertically integrated healthcare delivery system. With CenterWell expanding into 11 states and entering 4 new markets, they&#8217;re building something unique: insurance coverage combined with actual care provision.<\/p>\n<p>The company dominates Medicare Advantage with approximately 28% market share among major providers. Their secret sauce? The CenterWell primary care model where doctors spend 50% more time with patients than typical providers, creating better outcomes and lower costs.<\/p>\n<p><strong>Interesting 2025 Fact<\/strong>: Humana&#8217;s research partnership with Harvard proved their value-based care model delivers superior access compared to traditional primary care. They&#8217;re not just selling insurance\u2014they&#8217;re reinventing senior healthcare delivery.<\/p>\n"},"faq":[{"question":"Is Humana a good long-term investment despite regulatory challenges?","answer":"Yes, for patient investors. The demographic trend of aging population provides strong tailwinds, and their integrated care model is industry-leading once regulatory dust settles."},{"question":"What's the biggest risk facing HUM stock?","answer":"CMS regulatory changes. The expansion from 40 to 2,000 medical coders auditing risk adjustment data could significantly impact revenue if past coding practices face scrutiny."},{"question":"How often does Humana pay dividends?","answer":"Humana pays quarterly dividends, currently yielding around 0.9%. However, the company prioritizes growth investments over high dividend payments."},{"question":"Should I buy before or after earnings?","answer":"Historically, buying after earnings reactions has provided better entries. HUM often beats estimates but guidance commentary moves prices more than actual results."},{"question":"What makes CenterWell different from competitors?","answer":"True integration\u2014they're not just contracting with providers but actually employing doctors and building clinics specifically designed for senior care with longer appointments and comprehensive services."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Is Humana a good long-term investment despite regulatory challenges?","answer":"Yes, for patient investors. The demographic trend of aging population provides strong tailwinds, and their integrated care model is industry-leading once regulatory dust settles."},{"question":"What's the biggest risk facing HUM stock?","answer":"CMS regulatory changes. The expansion from 40 to 2,000 medical coders auditing risk adjustment data could significantly impact revenue if past coding practices face scrutiny."},{"question":"How often does Humana pay dividends?","answer":"Humana pays quarterly dividends, currently yielding around 0.9%. However, the company prioritizes growth investments over high dividend payments."},{"question":"Should I buy before or after earnings?","answer":"Historically, buying after earnings reactions has provided better entries. HUM often beats estimates but guidance commentary moves prices more than actual results."},{"question":"What makes CenterWell different from competitors?","answer":"True integration\u2014they're not just contracting with providers but actually employing doctors and building clinics specifically designed for senior care with longer appointments and comprehensive services."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Humana Inc. (HUM) shares - Investment in Humana Inc. (HUM) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Humana Inc. (HUM) shares - Investment in Humana Inc. (HUM) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-19T19:11:39+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Humana Inc. (HUM) shares &#8211; Investment in Humana Inc. (HUM) stock\",\"datePublished\":\"2025-08-19T19:11:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/\"},\"wordCount\":15,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/\",\"name\":\"How to buy Humana Inc. (HUM) shares - Investment in Humana Inc. (HUM) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"datePublished\":\"2025-08-19T19:11:39+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Humana Inc. (HUM) shares &#8211; Investment in Humana Inc. (HUM) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Humana Inc. (HUM) shares - Investment in Humana Inc. (HUM) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Humana Inc. (HUM) shares - Investment in Humana Inc. (HUM) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-19T19:11:39+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Humana Inc. (HUM) shares &#8211; Investment in Humana Inc. (HUM) stock","datePublished":"2025-08-19T19:11:39+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/"},"wordCount":15,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/","name":"How to buy Humana Inc. (HUM) shares - Investment in Humana Inc. (HUM) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","datePublished":"2025-08-19T19:11:39+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-humana\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Humana Inc. (HUM) shares &#8211; Investment in Humana Inc. (HUM) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":339904,"slug":"how-to-buy-humana","post_title":"Comment acheter des actions Humana Inc. (HUM) - Investir dans les actions Humana Inc. (HUM)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-humana\/"},"it_IT":{"locale":"it_IT","id":339910,"slug":"how-to-buy-humana","post_title":"Come acquistare azioni Humana Inc. (HUM) - Investire in azioni Humana Inc. (HUM)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-humana\/"},"pl_PL":{"locale":"pl_PL","id":339913,"slug":"how-to-buy-humana","post_title":"Jak kupi\u0107 akcje Humana Inc. (HUM) - Inwestycja w akcje Humana Inc. (HUM)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-humana\/"},"es_ES":{"locale":"es_ES","id":339905,"slug":"how-to-buy-humana","post_title":"C\u00f3mo comprar acciones de Humana Inc. (HUM) - Inversi\u00f3n en acciones de Humana Inc. (HUM)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-humana\/"},"th_TH":{"locale":"th_TH","id":339909,"slug":"how-to-buy-humana","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Humana Inc. (HUM) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Humana Inc. (HUM)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-humana\/"},"tr_TR":{"locale":"tr_TR","id":339912,"slug":"how-to-buy-humana","post_title":"Humana Inc. (HUM) Hisseleri Nas\u0131l Al\u0131n\u0131r - Humana Inc. (HUM) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-humana\/"},"vt_VT":{"locale":"vt_VT","id":339911,"slug":"how-to-buy-humana","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Humana Inc. (HUM) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Humana Inc. (HUM)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-humana\/"},"pt_AA":{"locale":"pt_AA","id":339906,"slug":"how-to-buy-humana","post_title":"Como comprar a\u00e7\u00f5es da Humana Inc. (HUM) - Investimento em a\u00e7\u00f5es da Humana Inc. (HUM)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-humana\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/339862","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=339862"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/339862\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334027"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=339862"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=339862"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=339862"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}